These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29407477)

  • 1. Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats.
    Levin ED; Wells C; Slade S; Rezvani AH
    Pharmacol Biochem Behav; 2018 Mar; 166():42-47. PubMed ID: 29407477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, reduces nicotine self-administration in rats.
    Rezvani AH; Wells C; Slade S; Xiao Y; Kellar KJ; Levin ED
    Pharmacol Biochem Behav; 2019 Apr; 179():109-112. PubMed ID: 30794849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α4β2 Nicotinic receptor desensitizing compounds can decrease self-administration of cocaine and methamphetamine in rats.
    Levin ED; Rezvani AH; Wells C; Slade S; Yenugonda VM; Liu Y; Brown ML; Xiao Y; Kellar KJ
    Eur J Pharmacol; 2019 Feb; 845():1-7. PubMed ID: 30529197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.
    Rezvani AH; Slade S; Wells C; Petro A; Lumeng L; Li TK; Xiao Y; Brown ML; Paige MA; McDowell BE; Rose JE; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2010 Aug; 211(2):161-74. PubMed ID: 20535453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats.
    Johnson JE; Slade S; Wells C; Petro A; Sexton H; Rezvani AH; Brown ML; Paige MA; McDowell BE; Xiao Y; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2012 Jul; 222(2):269-76. PubMed ID: 22297831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Paterson NE; Min W; Hackett A; Lowe D; Hanania T; Caldarone B; Ghavami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1455-64. PubMed ID: 20708056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential efficacies of the nicotinic α4β2 desensitizing agents in reducing nicotine self-administration in female rats.
    Rezvani AH; Slade S; Wells C; Yenugonda VM; Liu Y; Brown ML; Xiao Y; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2017 Sep; 234(17):2517-2523. PubMed ID: 28555315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, on body temperature regulation in mice and rats.
    Rezvani AH; Timofeeva O; Sexton HG; DeCuir D; Xiao Y; Gordon CJ; Kellar KJ; Levin ED
    Eur J Pharmacol; 2012 May; 682(1-3):110-7. PubMed ID: 22387853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.
    Levin ED; Rezvani AH; Xiao Y; Slade S; Cauley M; Wells C; Hampton D; Petro A; Rose JE; Brown ML; Paige MA; McDowell BE; Kellar KJ
    J Pharmacol Exp Ther; 2010 Mar; 332(3):933-9. PubMed ID: 20007754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextromethorphan interactions with histaminergic and serotonergic treatments to reduce nicotine self-administration in rats.
    Briggs SA; Hall BJ; Wells C; Slade S; Jaskowski P; Morrison M; Rezvani AH; Rose JE; Levin ED
    Pharmacol Biochem Behav; 2016 Mar; 142():1-7. PubMed ID: 26704812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.
    Hussmann GP; Turner JR; Lomazzo E; Venkatesh R; Cousins V; Xiao Y; Yasuda RP; Wolfe BB; Perry DC; Rezvani AH; Levin ED; Blendy JA; Kellar KJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):441-50. PubMed ID: 22899752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption.
    Touchette JC; Maertens JJ; Mason MM; O'Rourke KY; Lee AM
    Neuropharmacology; 2018 May; 133():63-74. PubMed ID: 29355641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic sazetidine-A, a selective α4β2 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats.
    Rezvani AH; Cauley M; Xiao Y; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2013 Mar; 226(1):35-43. PubMed ID: 23100170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats.
    Rezvani AH; Cauley M; Sexton H; Xiao Y; Brown ML; Paige MA; McDowell BE; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2011 Jun; 215(4):621-30. PubMed ID: 21274704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug.
    Cucchiaro G; Xiao Y; Gonzalez-Sulser A; Kellar KJ
    Anesthesiology; 2008 Sep; 109(3):512-9. PubMed ID: 18719450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine.
    Struthers AM; Wilkinson JL; Dwoskin LP; Crooks PA; Bevins RA
    Pharmacol Biochem Behav; 2009 Dec; 94(2):319-28. PubMed ID: 19778551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.
    Liu X
    Psychopharmacology (Berl); 2013 Nov; 230(2):203-13. PubMed ID: 23712602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
    Turner JR; Wilkinson DS; Poole RL; Gould TJ; Carlson GC; Blendy JA
    Neuropsychopharmacology; 2013 Sep; 38(10):2035-47. PubMed ID: 23624742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.
    Zakharova ES; Danysz W; Bespalov AY
    Psychopharmacology (Berl); 2005 Apr; 179(1):128-35. PubMed ID: 15682308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing nicotinic receptor activity and the spatial learning impairment caused by the NMDA glutamate antagonist dizocilpine in rats.
    Burke DA; Heshmati P; Kholdebarin E; Levin ED
    Eur J Pharmacol; 2014 Oct; 741():132-9. PubMed ID: 25064338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.